#United States #San Francisco #AI Detection #Eko Health #Clinical Advisory

Eko Health Expands Clinical Advisory Board to Enhance AI-Driven Disease Detection

In a significant move to boost the efficacy and reach of its AI-powered disease detection system, Eko Health has announced the expansion of its Clinical Advisory Board. This initiative aims to enhance the company's mission of transforming heart and lung disease management through cutting-edge technology. The newly expanded board is uniquely positioned to provide strategic support in clinical research, product development, and the implementation of Eko's innovative healthcare solutions.

Noteworthy Leadership

The board will be chaired by Dr. Steve Steinhubl, a renowned cardiologist and a Professor of Biomedical Engineering at Purdue University. Dr. Steinhubl previously led pioneering efforts in wearable health technologies as the Director of Digital Medicine at the Scripps Translational Science Institute. Under his guidance, the board is expected to drive clinical insights into everyday practices, allowing Eko to revolutionize the detection of cardiopulmonary diseases.

Dr. Steinhubl expressed enthusiasm about Eko's transformative approach: "Eko has turned the traditional stethoscope into a powerful tool for AI-driven disease detection. This advisory board is crucial in ensuring that our technological advancements effectively reach clinicians and patients, maximizing the benefits of early detection."

The expanded board features several distinguished health professionals:

• - Dr. Ankeet Bhatt: A cardiologist and clinical investigator at Kaiser Permanente San Francisco Medical Center.
• - Dr. Antoine Keller: Cardiothoracic surgeon at Ochsner Lafayette General Hospital and co-founder of HeartSense.
• - Dr. Joanna Kmiecik: Family medicine physician and Medical Director at Oak Street Health.
• - Dr. Jennifer Kwan: Cardiologist and assistant professor at Yale University specializing in cardiovascular imaging.
• - Dr. Lisa Rotenstein: Primary care physician at UCSF Health and director focused on advancing digital healthcare practices.
• - Dr. James Thomas: Cardiologist and director at Northwestern University focused on heart valve disease.

According to Connor Landgraf, CEO and Co-Founder of Eko Health, the diverse expertise represented on the Clinical Advisory Board is vital for the company's growth: "Our board consists of leading minds in healthcare who are leveraging technology to redefine patient care. Their insights will help us ensure responsible advancements in AI detection tools."

Recent Accomplishments

This announcement coincides with a series of impressive clinical milestones for Eko Health, including key FDA clearances for important disease detection algorithms related to low ejection fractions and structural murmurs. Furthermore, peer-reviewed validation studies have been released in prestigious publications such as Nature Medicine, The Lancet Digital Health, and JACC Advances. Recently, Eko also introduced a new Category III CPT® code, effective July 1, 2025, solidifying its standing in the cardiopulmonary care sector.

Eko Health has already sold over 650,000 devices globally, contributing to improved early detection and management of cardiovascular and pulmonary conditions. The company's offerings—which include advanced digital stethoscopes, ECG devices, and AI-powered analytics—reflect its commitment to empowering healthcare professionals and improving patient outcomes.

As the healthcare landscape evolves, especially in the realm of artificial intelligence and telehealth, Eko Health's proactive expansion of its Clinical Advisory Board is a strategic step that underscores its dedication to being at the forefront of technological innovation in medical care. The company's future initiatives will undoubtedly continue to change the way heart and lung diseases are diagnosed and treated, ultimately delivering better health outcomes for patients everywhere.

For more information about Eko Health and its transformative healthcare technologies, visit ekohealth.com.